Antoine Lampron

发表

Frequent mutations of β‐catenin gene in sporadic secreting adrenocortical adenomas *

I. Bourdeau, A. Lampron, Mimi Tadjine, 2007, Clinical endocrinology.

Inefficient clearance of myelin debris by microglia impairs remyelinating processes

Peter K. Stys, V. Wee Yong, M. Tremblay, 2015, The Journal of experimental medicine.

Aberrant G‐protein coupled receptor expression in relation to adrenocortical overfunction

P. Hamet, J. Tremblay, A. Lacroix, 2009, Clinical endocrinology.

Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma.

W. Schürch, P. Hamet, A. Lacroix, 2009, The Journal of clinical endocrinology and metabolism.

ACTH-Independent Cushing’s Syndrome: Bilateral Macronodular Hyperplasia

A. Lacroix, T. L. Mazzuco, I. Bourdeau, 2010 .

Innate Immunity in the CNS: Redefining the Relationship between the CNS and Its Environment

S. Rivest, A. ElAli, A. Lampron, 2013, Neuron.

Aberrant Hormone Receptors in Primary Aldosteronism

A. Lacroix, T. L. Mazzuco, I. Bourdeau, 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Bone Marrow Chimeras to Study Neuroinflammation

S. Rivest, N. Laflamme, A. Lampron, 2018, Current protocols in immunology.

Tissue-Plasminogen Activator Attenuates Alzheimer’s Disease-Related Pathology Development in APPswe/PS1 Mice

S. Rivest, M. Filali, A. ElAli, 2016, Neuropsychopharmacology.

Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer’s disease-related pathology

Jean-Philippe Michaud, S. Rivest, C. Cluff, 2013, Proceedings of the National Academy of Sciences.

Targeting the hematopoietic system for the treatment of Alzheimer’s disease

S. Rivest, D. Gosselin, A. Lampron, 2011, Brain, Behavior, and Immunity.

Detection of somatic β‐catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD)

C. Stratakis, A. Horvath, I. Bourdeau, 2008, Clinical endocrinology.

Adrenocorticotropic hormone-independent Cushing's syndrome

A. Lacroix, I. Bourdeau, A. Lampron, 2007, Current opinion in endocrinology, diabetes, and obesity.

Migration of Bone Marrow-Derived Cells Into the Central Nervous System in Models of Neurodegeneration: Naturally occurring migration of BMDC into the CNS

S. Rivest, P. Pimentel-Coelho, A. Lampron, 2013 .

Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.

T. L. Mazzuco, I. Bourdeau, A. Lampron, 2011, The Journal of clinical endocrinology and metabolism.

Migration of Bone Marrow‐Derived Cells Into the Central Nervous System in Models of Neurodegeneration

S. Rivest, P. Pimentel-Coelho, A. Lampron, 2013, The Journal of comparative neurology.

Alzheimer's pathology: should peripheral monocytes and CCR2 take center stage?

D. Melzer, L. Pilling, L. Harries, 2013 .

Effects of Myeloablation, Peripheral Chimerism, and Whole-Body Irradiation on the Entry of Bone Marrow-Derived Cells into the Brain

S. Rivest, A. Lampron, M. Lessard, 2012, Cell transplantation.

Targeting the hematopoietic system for the treatment of Alzheimer’s disease

S. Rivest, D. Gosselin, Antoine Lampron, 2011, Brain, Behavior, and Immunity.

Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma.

W. Schürch, P. Hamet, A. Lacroix, 2009, The Journal of clinical endocrinology and metabolism.

Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome.

P. Hamet, J. Tremblay, A. Lacroix, 2006, The Journal of clinical endocrinology and metabolism.